Verwandte Artikel zu Mesenchymal Stem Cell Therapy (Stem Cell Biology and...

Mesenchymal Stem Cell Therapy (Stem Cell Biology and Regenerative Medicine) - Softcover

 
9781627039147: Mesenchymal Stem Cell Therapy (Stem Cell Biology and Regenerative Medicine)
Alle Exemplare der Ausgabe mit dieser ISBN anzeigen:
 
 
Reseña del editor:

Over the past decade, significant efforts have been made to develop stem cell-based therapies for difficult to treat diseases. Multipotent mesenchymal stromal cells, also referred to as mesenchymal stem cells (MSCs), appear to hold great promise in regards to a regenerative cell-based therapy for the treatment of these diseases. Currently, more than 200 clinical trials are underway worldwide exploring the use of MSCs for the treatment of a wide range of disorders including bone, cartilage and tendon damage, myocardial infarction, graft-versus-host disease, Crohn’s disease, diabetes, multiple sclerosis, critical limb ischemia and many others.

 

MSCs were first identified by Friendenstein and colleagues as an adherent stromal cell population within the bone marrow with the ability to form clonogenic colonies in vitro.  In regards to the basic biology associated with MSCs, there has been tremendous progress towards understanding this cell population’s phenotype and function from a range of tissue sources.  Despite enormous progress and an overall increased understanding of MSCs at the molecular and cellular level, several critical questions remain to be answered in regards to the use of these cells in therapeutic applications.  Clinically, both autologous and allogenic approaches for the transplantation of MSCs are being explored.  Several of the processing steps needed for the clinical application of MSCs, including isolation from various tissues, scalable in vitro expansion, cell banking, dose preparation, quality control parameters, delivery methods and numerous others are being extensively studied.   Despite a significant number of ongoing clinical trials, none of the current therapeutic approaches have, at this point, become a standard of care treatment.  Although exceptionally promising, the clinical translation of MSC-based therapies is still a work in progress.

 

The extensive number of ongoing clinical trials is expected to provide a clearer path forward for the realization and implementation of MSCs in regenerative medicine. Towards this end, reviews of current clinical trial results and discussions of relevant topics association with the clinical application of MSCs are compiled in this book from some of the leading researchers in this exciting and rapidly advancing field.  Although not absolutely all-inclusive, we hope the chapters within this book can promote and enable a better understanding of the translation of MSCs from bench-to-bedside and inspire researchers to further explore this promising and quickly evolving field.
Contraportada:

Mesenchymal Stem Cells or Multipotent Mesenchymal Stromal Cells (collectively referred to as MSCs) are currently being tested in a number of clinical trials for various diseases including graft-versus-host disease, Crohn’s disease, myocardial infarction, stroke, diabetes, cartilage defects, and many others. The increasing number of clinical trials globally indicates the likely therapeutic potential of this specialized adult stem cell.  Over the last decade, there has been tremendous progress towards understanding an MSC’s phenotype, expansion features in culture, differentiation ability and global gene and protein expression profiles.  Despite the enormous progress and data accrual at the molecular and cellular levels, several questions remain as to the utility of MSCs for clinical applications. 

 

Mesenchymal Stem Cell Therapy is a comprehensive collection of information comprised of both basic and pre-clinical biological studies as well as current advances in clinical applications within the MSC therapy field.  This text is a resource for both the basic life science and cell therapy researchers and includes a spectrum of review chapters from top experts in the field discussing clinical scale culture, regulatory issues, genetic engineering, disease specific applications and others.

„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.

Weitere beliebte Ausgaben desselben Titels

9781627031998: Mesenchymal Stem Cell Therapy (Stem Cell Biology and Regenerative Medicine)

Vorgestellte Ausgabe

ISBN 10:  1627031995 ISBN 13:  9781627031998
Verlag: Humana, 2012
Hardcover

  • 9781627032018: Mesenchymal Stem Cell Therapy

    Springer, 2012
    Softcover

Beste Suchergebnisse bei AbeBooks

Foto des Verkäufers

Verlag: Humana (2015)
ISBN 10: 1627039147 ISBN 13: 9781627039147
Neu Soft Cover Anzahl: 1
Anbieter:
booksXpress
(Bayonne, NJ, USA)
Bewertung

Buchbeschreibung Soft Cover. Zustand: new. Bestandsnummer des Verkäufers 9781627039147

Weitere Informationen zu diesem Verkäufer | Verkäufer kontaktieren

Neu kaufen
EUR 162,18
Währung umrechnen

In den Warenkorb

Versand: Gratis
Innerhalb der USA
Versandziele, Kosten & Dauer
Beispielbild für diese ISBN

Verlag: Humana (2015)
ISBN 10: 1627039147 ISBN 13: 9781627039147
Neu Softcover Anzahl: > 20
Anbieter:
Lucky's Textbooks
(Dallas, TX, USA)
Bewertung

Buchbeschreibung Zustand: New. Bestandsnummer des Verkäufers ABLIING23Mar2811580170299

Weitere Informationen zu diesem Verkäufer | Verkäufer kontaktieren

Neu kaufen
EUR 171,92
Währung umrechnen

In den Warenkorb

Versand: EUR 3,73
Innerhalb der USA
Versandziele, Kosten & Dauer
Foto des Verkäufers

Mohan C Vemuri
ISBN 10: 1627039147 ISBN 13: 9781627039147
Neu Taschenbuch Anzahl: 2
Print-on-Demand
Anbieter:
BuchWeltWeit Ludwig Meier e.K.
(Bergisch Gladbach, Deutschland)
Bewertung

Buchbeschreibung Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Over the past decade, significant efforts have been made to develop stem cell-based therapies for difficult to treat diseases. Multipotent mesenchymal stromal cells, also referred to as mesenchymal stem cells (MSCs), appear to hold great promise in regards to a regenerative cell-based therapy for the treatment of these diseases. Currently, more than 200 clinical trials are underway worldwide exploring the use of MSCs for the treatment of a wide range of disorders including bone, cartilage and tendon damage, myocardial infarction, graft-versus-host disease, Crohn's disease, diabetes, multiple sclerosis, critical limb ischemia and many others. MSCs were first identified by Friendenstein and colleagues as an adherent stromal cell population within the bone marrow with the ability to form clonogenic colonies in vitro. In regards to the basic biology associated with MSCs, there has been tremendous progress towards understanding this cell population's phenotype and function from a range of tissue sources. Despite enormous progress and an overall increased understanding of MSCs at the molecular and cellular level, several critical questions remain to be answered in regards to the use of these cells in therapeutic applications. Clinically, both autologous and allogenic approaches for the transplantation of MSCs are being explored. Several of the processing steps needed for the clinical application of MSCs, including isolation from various tissues, scalable in vitro expansion, cell banking, dose preparation, quality control parameters, delivery methods and numerous others are being extensively studied. Despite a significant number of ongoing clinical trials, none of the current therapeutic approaches have, at this point, become a standard of care treatment. Although exceptionally promising, the clinical translation of MSC-based therapies is still a work in progress. The extensive number of ongoing clinical trials is expected to provide a clearer path forward for the realization and implementation of MSCs in regenerative medicine. Towards this end, reviews of current clinical trial results and discussions of relevant topics association with the clinical application of MSCs are compiled in this book from some of the leading researchers in this exciting and rapidly advancing field. Although not absolutely all-inclusive, we hope the chapters within this book can promote and enable a better understanding of the translation of MSCs from bench-to-bedside and inspire researchers to further explore this promising and quickly evolving field. 468 pp. Englisch. Bestandsnummer des Verkäufers 9781627039147

Weitere Informationen zu diesem Verkäufer | Verkäufer kontaktieren

Neu kaufen
EUR 159,99
Währung umrechnen

In den Warenkorb

Versand: EUR 23,00
Von Deutschland nach USA
Versandziele, Kosten & Dauer
Foto des Verkäufers

Chase, Lucas G.|Vemuri, Mohan C.
Verlag: Humana Press (2015)
ISBN 10: 1627039147 ISBN 13: 9781627039147
Neu Softcover Anzahl: > 20
Print-on-Demand
Anbieter:
moluna
(Greven, Deutschland)
Bewertung

Buchbeschreibung Zustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Includes reviews of current clinical trial results and discussions of relevant topics Promotes a better understanding of the translation of MSCs from bench-to-bedsideWritten by some of the leading researchers in this exciting and rapidly ad. Bestandsnummer des Verkäufers 448181574

Weitere Informationen zu diesem Verkäufer | Verkäufer kontaktieren

Neu kaufen
EUR 137,02
Währung umrechnen

In den Warenkorb

Versand: EUR 48,99
Von Deutschland nach USA
Versandziele, Kosten & Dauer
Beispielbild für diese ISBN

Lucas G. Chase
Verlag: Humana (2015)
ISBN 10: 1627039147 ISBN 13: 9781627039147
Neu Softcover Anzahl: > 20
Print-on-Demand
Anbieter:
Ria Christie Collections
(Uxbridge, Vereinigtes Königreich)
Bewertung

Buchbeschreibung Zustand: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Bestandsnummer des Verkäufers ria9781627039147_lsuk

Weitere Informationen zu diesem Verkäufer | Verkäufer kontaktieren

Neu kaufen
EUR 177,47
Währung umrechnen

In den Warenkorb

Versand: EUR 11,66
Von Vereinigtes Königreich nach USA
Versandziele, Kosten & Dauer
Foto des Verkäufers

Mohan C Vemuri
Verlag: Humana Press (2015)
ISBN 10: 1627039147 ISBN 13: 9781627039147
Neu Taschenbuch Anzahl: 1
Print-on-Demand
Anbieter:
AHA-BUCH GmbH
(Einbeck, Deutschland)
Bewertung

Buchbeschreibung Taschenbuch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Over the past decade, significant efforts have been made to develop stem cell-based therapies for difficult to treat diseases. Multipotent mesenchymal stromal cells, also referred to as mesenchymal stem cells (MSCs), appear to hold great promise in regards to a regenerative cell-based therapy for the treatment of these diseases. Currently, more than 200 clinical trials are underway worldwide exploring the use of MSCs for the treatment of a wide range of disorders including bone, cartilage and tendon damage, myocardial infarction, graft-versus-host disease, Crohn's disease, diabetes, multiple sclerosis, critical limb ischemia and many others. MSCs were first identified by Friendenstein and colleagues as an adherent stromal cell population within the bone marrow with the ability to form clonogenic colonies in vitro. In regards to the basic biology associated with MSCs, there has been tremendous progress towards understanding this cell population's phenotype and function from a range of tissue sources. Despite enormous progress and an overall increased understanding of MSCs at the molecular and cellular level, several critical questions remain to be answered in regards to the use of these cells in therapeutic applications. Clinically, both autologous and allogenic approaches for the transplantation of MSCs are being explored. Several of the processing steps needed for the clinical application of MSCs, including isolation from various tissues, scalable in vitro expansion, cell banking, dose preparation, quality control parameters, delivery methods and numerous others are being extensively studied. Despite a significant number of ongoing clinical trials, none of the current therapeutic approaches have, at this point, become a standard of care treatment. Although exceptionally promising, the clinical translation of MSC-based therapies is still a work in progress. The extensive number of ongoing clinicaltrials is expected to provide a clearer path forward for the realization and implementation of MSCs in regenerative medicine. Towards this end, reviews of current clinical trial results and discussions of relevant topics association with the clinical application of MSCs are compiled in this book from some of the leading researchers in this exciting and rapidly advancing field. Although not absolutely all-inclusive, we hope the chapters within this book can promote and enable a better understanding of the translation of MSCs from bench-to-bedside and inspire researchers to further explore this promising and quickly evolving field. Bestandsnummer des Verkäufers 9781627039147

Weitere Informationen zu diesem Verkäufer | Verkäufer kontaktieren

Neu kaufen
EUR 163,54
Währung umrechnen

In den Warenkorb

Versand: EUR 32,99
Von Deutschland nach USA
Versandziele, Kosten & Dauer